What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?

類似資料

• Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures
  著者:: Taxonera, Carlos, 等
  出版事項: (2020)
• 2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases
  著者:: Taxonera, Carlos, 等
  出版事項: (2020)
• Letter: immunotherapy for IBD patients in a SARS‐CoV‐2 endemic area—authors' reply
  著者:: Taxonera, Carlos, 等
  出版事項: (2020)
• Can COVID-19 Trigger De Novo Inflammatory Bowel Disease?
  著者:: Taxonera, Carlos, 等
  出版事項: (2021)
• Letter: intestinal inflammation, COVID‐19 and gastrointestinal ACE2—exploring RAS inhibitors. Authors’ reply
  著者:: Taxonera, Carlos, 等
  出版事項: (2020)